Skip to content
lifestyle.gooddecisions.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Femasys Inc.
Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
September 15, 2026
Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio
September 9, 2026
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
August 26, 2026
Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®
August 20, 2026
Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
August 17, 2026
Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
August 12, 2026
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
August 7, 2026
Femasys Regains Compliance with Nasdaq Listing Requirements
June 24, 2026
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
May 21, 2026
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
May 18, 2026
1
2
3
Next Page
→